rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
GUFIC BIOSCIENCES LTD. - Board Meeting Outcome for Outcome Of The Board Meeting
Download announcement < Back
19 Apr 2022
Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (&apos;SEBI Regulations&apos;), we would like to inform that the Board of Directors at their meeting held on April 19, 2022 i.e., today, inter alia approved the following agenda item: Signing of Equity Subscription Agreement with M/s. Selvax Pty Limited (&apos;Selvax&apos;), a biotechnology company based in Perth, Western Australia, for subscription of 1,307,000 fully paid ordinary equity shares in Selvax aggregating to 2.67% of its total paid up share capital for a subscription fee of around USD 0.07651 per equity share aggregating to USD 100,000/- Kindly note that the Company have also entered into a research and collaboration agreement with Selvax to accelerate the commercialization of Selvax&apos;s cancer immunotherapy treatment. Kindly take the same on your record.
View all announcements for GUFIC BIOSCIENCES LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips